SecurityECC / Eagle Point Credit Company Inc. (269808101)
Institutional Owners36 (5 N-Q Owners)
Institutional Shares19,245,480 (ex. N-Q)
Institutional Value$ 205,786,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

Eagle Point Credit Company Inc. (NYSE:ECC) has 36 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 19,245,480 shares. Largest shareholders include Stone Point Capital Llc, Trident V, L.p., Eagle Point Credit Management Llc, Oa Eagle Group Investors, Llc, Enstar Group LTD, Mycio Wealth Partners, Llc, Karpus Management, Inc., Freestone Capital Holdings, LLC, Thomas J. Herzfeld Advisors, Inc., and Manufacturers Life Insurance Company, The.
Eagle Point Credit Company Inc. (NYSE:ECC) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Prev Value
Current Value
2018-05-09 13F-HR STONE POINT CAPITAL LLC 8,609,357 8,609,357 0.00 161,942 156,174 -3.56
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 4,978 5,228 5.02 94 95 1.06
2018-05-14 13F-HR Baird Financial Group, Inc. 39,747 47,004 18.26 748 853 14.04
2018-04-27 13F-HR MYCIO WEALTH PARTNERS, LLC 1,104,410 1,136,079 2.87 20,774 20,608 -0.80
2018-02-14 13F-HR Belpointe Asset Management Llc 22,059 15,797 -28.39 456 297 -34.87
2018-05-10 13F-HR BESSEMER GROUP INC 4,987 4,987 0.00 94 90 -4.26
2018-05-01 13F-HR OPPENHEIMER & CO INC 10,534 191
2018-05-11 13F-HR CITIGROUP INC 3,000 13,242 341.40 56 240 328.57
2018-05-18 SC 13D Eagle Point Credit Management Llc 1,457,589
2018-05-10 13F-HR Wagner Wealth Management, Llc 250 250 0.00 5 5 0.00
2018-05-11 SC 13G Karpus Management, Inc. 512,835 505,735 -1.38
2018-05-14 13F-HR BARD ASSOCIATES INC 131,358 131,233 -0.10 2,471 2,381 -3.64
2018-05-11 13F-HR Relative Value Partners Group, LLC 45,942 47,823 4.09 864 868 0.46
2018-05-14 13F-HR MORGAN STANLEY 4,997 8,564 71.38 94 155 64.89
2018-02-14 13F-HR BLAIR WILLIAM & CO/IL 19,800 0 -100.00 410 0 -100.00
2018-05-15 13F-HR Penn Mutual Life Insurance Co 82,000 1,485
2018-05-15 13F-HR Freestone Capital Holdings, LLC 335,874 335,915 0.01 6,318 6,093 -3.56
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 219,967 219,967 0.00 4,138 3,990 -3.58
2018-05-15 13F-HR Thomas J. Herzfeld Advisors, Inc. 5,511 322,655 5,754.75 104 5,853 5,527.88
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 206,376 206,376 0.00 3,882 3,744 -3.55
2018-02-09 13F-HR Tower Research Capital LLC (TRC) 178 0 -100.00 4 0 -100.00
2018-02-02 SC 13G/A Enstar Group LTD 1,250,616 1,172,757 -6.23
2018-05-17 N-Q Advisorshares Trust (see advisory)
2018-05-14 13F-HR ARES MANAGEMENT LLC 51,550 71,250 38.22 970 1,292 33.20
2018-05-07 13F-HR Focused Wealth Management, Inc 380 7
2018-04-20 N-Q Graniteshares Etf Trust (see advisory)
2018-05-14 13F-HR Evercore Wealth Management, LLC 5,000 0 -100.00 94 0 -100.00
2018-05-15 13F-HR UBS Group AG 461 800 73.54 9 15 66.67
2018-02-28 N-Q Virtus Opportunities Trust (see advisory)
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 1,220 1,520 24.59 23 28 21.74
2018-05-21 SC 13G Oa Eagle Group Investors, Llc 1,429,041 1,429,041 0.00
2018-05-01 13F-HR Plante Moran Financial Advisors, LLC 1,619 1,672 3.27 30 30 0.00
2018-04-02 N-Q Two Roads Shared Trust (see advisory)
2018-02-07 13F-HR Penserra Capital Management LLC 228 0 -100.00 4 0 -100.00
2018-01-29 N-Q Starboard Investment Trust (see advisory)
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 22,020 399
2018-05-01 13F-HR WEDBUSH SECURITIES INC 17,550 16,050 -8.55 330 291 -11.82
2018-05-15 SC 13D/A TRIDENT V, L.P. 3,336,437
2018-05-15 13F-HR National Asset Management, Inc. 17,154 17,639 2.83 323 320 -0.93
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 13,574 15,579 14.77 255 282 10.59

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.


  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( ECC / Eagle Point Credit Company Inc. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

2018-05-25 - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

2018-05-25 - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

Related News Stories

Dividend Cuts - Managing Their Impact On Our 'Income Factory'

2018-05-21 seekingalpha
Dividend cuts are an inescapable risk in any investment strategy, especially our Income Factory strategy that depends on re-investing and compounding a steady stream of cash.

Weekly CEF Roundup: DSE Cuts Distribution By -31%

2018-05-21 seekingalpha
The Weekly CEF Roundup will be put out at the start of each week to summarize recent price movements in closed-end fund (NYSEMKT:CEF) sectors in the last week, as well as to highlight recently concluded or upcoming corporate actions on CEFs, such as tender offers. Most of the information has been sourced from CEFInsight or the Closed-End Fund Center. I will also link to some articles from Seeking Alpha that I have found for useful reading over the past week. (6-0)

155 Monthly Pay SML Equities Show 1.85% To 17.92% Yields And 70 Funds Yield 7.16% To 19.5%

2018-05-21 seekingalpha
Here's your April 2018 Monthly-Paid (MoPay) Small-Mid-Large Cap Dividend, Yield, Upsides, and Net Gains Reports. Nano-Cap MoPays are not listed. (17-0)

Eagle Point Credit Company Inc. 2018 Q1 - Results - Earnings Call Slides

2018-05-18 seekingalpha
The following slide deck was published by Eagle Point Credit Company Inc. in conjunction with their 2018 Q1 earnings call.

Eagle Point Credit Company's (ECC) CEO Tom Majewski on Q1 2018 Results - Earnings Call Transcript

2018-05-17 seekingalpha
Eagle Point Credit Company Inc. (NYSE:ECC) Q1 2018 Earnings Conference Call May 17, 2018 10:00 AM ET (4-0)

CUSIP: 269808101